Es wurden 42 Produkte zu dem Suchbegriff screening tests in 6 Shops gefunden:

Anwendungsgebiet von Inoky-glucoscreen 50 G Lösung Zum EinnehmenDas Präparat ist eine Testlösung mit einer hohen Glucosekonzentration.Es wird für das Screening auf Schwangerschaftsdiabetes mit einem oralen Glucose Screening Test (oGST) verwendet.Der in diesem Präparat enthaltene Traubenzucker wird in den Körper aufgenommen, und in der Folgekommt es zu einem Anstieg des Blutzuckers. Der Arzt kann am Verlauf des Blutzuckerspiegels eine Vordiagnose zu Schwangerschaftsdiabetes stellen.Wirkstoffe / Inhaltsstoffe / Zutaten55 g Glucose 1-Wasser50 g GlucoseCitronensäure, wasserfrei Hilfstoff (+)Wasser, gereinigt Hilfstoff (+)354 mg Natrium benzoat Hilfstoff (+)57 mg Gesamt Natrium Ion Hilfstoff (+)Schwarze Johannisbeer Aroma Hilfstoff (+)GegenanzeigenDas Arzneimittel darf nicht eingenommen werden,wenn Sie allergisch gegen Glucose oder einen der sonstigen Bestandteile dieses Arzneimittels sind,wenn Sie unter körperlichem Stress stehen, z.B. nach einer Operation oder einem Trauma, oder wenn Sie an einem Infekt oder einer anderen akuten Erkrankung leiden,bei bekannter Zuckerkrankheit,nach Entfernung von Magen-Darmteilen (Magen-Darm-Resektion),bei stark vermindertem Allgemein- und Ernährungszustand,bei Elektrolytstörungen.DosierungDer Zuckerbelastungstest wird unter Aufsicht und nach Anweisung des Arztes oder geschulten medizinischen Personals durchgeführt.Die empfohlene Dosis für die Vordiagnose oder das Screening von Schwangerschaftsdiabetes beträgt 50 g. Daher muss der Inhalt der Flasche (entsprechend 50 g wasserfreie Glucose) in seiner Gesamtheit getrunken werden.Was müssen Sie bei der Vorbereitung auf den Test beachten?Arzneimittel, die den Zuckerbelastungstest beeinflussen können sind mindestens 3 Tage vor dem Test abzusetzen, sofern dies ohne Gefahr für Ihre Gesundheit möglich ist.Der Test kann unabhängig von der Tageszeit und ohne Beachtung der letzten Mahlzeit durchgeführt werden (Sie müssen nicht nüchtern sein).Der Test sollte zwischen der 24. und

ZOXS liefert ausschließlich verschweißte Neuware in 3-7 Tagen

Anwendungsgebiet von Inoky-glucoscreen 50 G Lösung Zum EinnehmenDas Präparat ist eine Testlösung mit einer hohen Glucosekonzentration.Es wird für das Screening auf Schwangerschaftsdiabetes mit einem oralen Glucose Screening Test (oGST) verwendet.Der in diesem Präparat enthaltene Traubenzucker wird in den Körper aufgenommen, und in der Folgekommt es zu einem Anstieg des Blutzuckers. Der Arzt kann am Verlauf des Blutzuckerspiegels eine Vordiagnose zu Schwangerschaftsdiabetes stellen.Wirkstoffe / Inhaltsstoffe / Zutaten55 g Glucose 1-Wasser50 g GlucoseCitronensäure, wasserfrei Hilfstoff (+)Wasser, gereinigt Hilfstoff (+)354 mg Natrium benzoat Hilfstoff (+)57 mg Gesamt Natrium Ion Hilfstoff (+)Schwarze Johannisbeer Aroma Hilfstoff (+)GegenanzeigenDas Arzneimittel darf nicht eingenommen werden,wenn Sie allergisch gegen Glucose oder einen der sonstigen Bestandteile dieses Arzneimittels sind,wenn Sie unter körperlichem Stress stehen, z.B. nach einer Operation oder einem Trauma, oder wenn Sie an einem Infekt oder einer anderen akuten Erkrankung leiden,bei bekannter Zuckerkrankheit,nach Entfernung von Magen-Darmteilen (Magen-Darm-Resektion),bei stark vermindertem Allgemein- und Ernährungszustand,bei Elektrolytstörungen.DosierungDer Zuckerbelastungstest wird unter Aufsicht und nach Anweisung des Arztes oder geschulten medizinischen Personals durchgeführt.Die empfohlene Dosis für die Vordiagnose oder das Screening von Schwangerschaftsdiabetes beträgt 50 g. Daher muss der Inhalt der Flasche (entsprechend 50 g wasserfreie Glucose) in seiner Gesamtheit getrunken werden.Was müssen Sie bei der Vorbereitung auf den Test beachten?Arzneimittel, die den Zuckerbelastungstest beeinflussen können sind mindestens 3 Tage vor dem Test abzusetzen, sofern dies ohne Gefahr für Ihre Gesundheit möglich ist.Der Test kann unabhängig von der Tageszeit und ohne Beachtung der letzten Mahlzeit durchgeführt werden (Sie müssen nicht nüchtern sein).Der Test sollte zwischen der 24. und

The process of discovery in science and technology may require investigation of a large number of features, such as factors, genes or molecules. In Screening, statistically designed experiments and analyses of the resulting data sets are used to identify efficiently the few features that determine key properties of the system under study. This book brings together accounts by leading international experts that are essential reading for those working in fields such as industrial quality improvement, engineering research and development, genetic and medical screening, drug discovery, and computer simulation of manufacturing systems or economic models. Our aim is to promote cross-fertilization of ideas and methods through detailed explanations, a variety of examples and extensive references. Topics cover both physical and computer simulated experiments. They include screening methods for detecting factors that affect the value of a response or its variability, and for choosing between various different response models. Screening for disease in blood samples, for genes linked to a disease and for new compounds in the search for effective drugs are also described. Statistical techniques include Bayesian and frequentist methods of data analysis, algorithmic methods for both the design and analysis of experiments, and the construction of fractional factorial designs and orthogonal arrays. The material is accessible to graduate and research statisticians, and to engineers and chemists with a working knowledge of statistical ideas and techniques. It will be of interest to practitioners and researchers who wish to learn about useful methodologies from within their own area as well as methodologies that can be translated from one area to another.

The process of discovery in science and technology may require investigation of a large number of features, such as factors, genes or molecules. In Screening, statistically designed experiments and analyses of the resulting data sets are used to identify efficiently the few features that determine key properties of the system under study. This book brings together accounts by leading international experts that are essential reading for those working in fields such as industrial quality improvement, engineering research and development, genetic and medical screening, drug discovery, and computer simulation of manufacturing systems or economic models. Our aim is to promote cross-fertilization of ideas and methods through detailed explanations, a variety of examples and extensive references. Topics cover both physical and computer simulated experiments. They include screening methods for detecting factors that affect the value of a response or its variability, and for choosing between various different response models. Screening for disease in blood samples, for genes linked to a disease and for new compounds in the search for effective drugs are also described. Statistical techniques include Bayesian and frequentist methods of data analysis, algorithmic methods for both the design and analysis of experiments, and the construction of fractional factorial designs and orthogonal arrays. The material is accessible to graduate and research statisticians, and to engineers and chemists with a working knowledge of statistical ideas and techniques. It will be of interest to practitioners and researchers who wish to learn about useful methodologies from within their own area as well as methodologies that can be translated from one area to another.

The process of discovery in science and technology may require investigation of a large number of features, such as factors, genes or molecules. In Screening, statistically designed experiments and analyses of the resulting data sets are used to identify efficiently the few features that determine key properties of the system under study. This book brings together accounts by leading international experts that are essential reading for those working in fields such as industrial quality improvement, engineering research and development, genetic and medical screening, drug discovery, and computer simulation of manufacturing systems or economic models. Our aim is to promote cross-fertilization of ideas and methods through detailed explanations, a variety of examples and extensive references. Topics cover both physical and computer simulated experiments. They include screening methods for detecting factors that affect the value of a response or its variability, and for choosing between various different response models. Screening for disease in blood samples, for genes linked to a disease and for new compounds in the search for effective drugs are also described. Statistical techniques include Bayesian and frequentist methods of data analysis, algorithmic methods for both the design and analysis of experiments, and the construction of fractional factorial designs and orthogonal arrays. The material is accessible to graduate and research statisticians, and to engineers and chemists with a working knowledge of statistical ideas and techniques. It will be of interest to practitioners and researchers who wish to learn about useful methodologies from within their own area as well as methodologies that can be translated from one area to another.

In Cancer Screening: A Practical Guide for Physicians, a panel of highly experienced clinicians and researchers from around the world present their up-to-date screening techniques for a wide variety of cancers. The techniques range from screening for breast, gynecological, and gastrointestinal cancers, to testing for urogenital, dermatological, and respiratory cancers. In addition to providing the busy practitioner with quick access to guidelines for particular cancers, the epidemiology and biology of the various cancers, as well as the sensitivity and specificity of the methods, are discussed in detail. Authoritative and physician-friendly, Cancer Screening: A Practical Guide for Physicians offers to all internists, oncologists, various subspecialists, and primary care physicians a concise practical review of cancer screening designed specifically for daily use in the consulting room.

There has always been some tension between proponents of hypothesis-driven and discovery-driven research in the broad field of life sciences. Academic research has been primarily focused on hypothesis-driven research. However, the success of the human genome project, a discovery-driven research approach, has opened the door to adding other types of discovery-driven research to a continuum of research approaches. In contrast, drug discovery research in the pharmaceutical industry has embraced discovery-driven research for many years. A good example has been the discovery of active compounds from large chemical libraries, through screening campaigns. The success of the human genome project has also demonstrated the need for both academic researchers and industrial researchers to now understand the functions of genes and gene products. The cell is the basic unit of life and it has been at the cellular level where function can be demonstrated most cost-effectively and rapidly. High content screening (HCS) was developed by Cellomics Inc. in the mid-1990s to address the need for a platform that could be used in the discovery-driven research and development required to understand the functions of genes and gene products at the level of the cell.

This second edition details some of the recent trends in HCS/HCA/HCI.  New and updated chapters guide readers through methods that utilize reagents and kits that have been developed to measure cells and subpopulation classifications, control measures, overviews of the data handling issues associated with HCS/HCA/HCI, and methods to implement more complex phenotypic models.  Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, High Content Screening and Analysis-The Ideal Format for Phenotypic Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery, Second Edition aims to ensure successful results in the further study of this vital field.

This second edition details some of the recent trends in HCS/HCA/HCI.  New and updated chapters guide readers through methods that utilize reagents and kits that have been developed to measure cells and subpopulation classifications, control measures, overviews of the data handling issues associated with HCS/HCA/HCI, and methods to implement more complex phenotypic models.  Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, High Content Screening and Analysis-The Ideal Format for Phenotypic Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery, Second Edition aims to ensure successful results in the further study of this vital field.

This second edition details some of the recent trends in HCS/HCA/HCI.  New and updated chapters guide readers through methods that utilize reagents and kits that have been developed to measure cells and subpopulation classifications, control measures, overviews of the data handling issues associated with HCS/HCA/HCI, and methods to implement more complex phenotypic models.  Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, High Content Screening and Analysis-The Ideal Format for Phenotypic Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery, Second Edition aims to ensure successful results in the further study of this vital field.

Wespenfalle2er-SatzProduktmerkmale:Effektive und e Wespenfalle für das ganze Haus.Spezielles Behälterdesign verhindert, dass die Insekten entkommen.Wiederverwendbares Produkt.Ideal für Garten und Balkon.Spezifikation:Durchmesser 8 cm, Höhe - 13 cm,Abmessungen der Verpackung: 9 x 20 x 15 cm,Satz von 2 Stück,Wiederverwendbar.Die Wespenfalle ist ein kleines, ovales Gerät, das aufgehängt oder aufgestellt werden kann. Sie hat einen Durchmesser von 8 cm und eine Höhe von 13 cm. Sie besteht aus zwei abschraubbaren Teilen, einem grünen und einem durchsichtigen. In den ersten wird die Köderflüssigkeit eingefüllt und aufgeschraubt. Im halbtransparenten Teil befindet sich eine Hülse, durch die angelockte Insekten einfliegen können, aber nicht ausfliegen können. Dank der Wespenfalle besteht bei sommerlichen Mahlzeiten im Freien keine Gefahr mehr, gestochen zu werden.

*Marburger Sprach-Screening (MSS) - Testbögen-Heft * - 10er-Pack Testbögen-Hefte (1. Klasse/Vorschule). komplett überarbeitete Neuauflage Nachdruck / 18.99€ / Bei Hugendubel

This detailed volume explores recent advances in phenotypic screening, such as high-resolution microscopy, high-throughput screening, and artificial intelligence (AI)-based image and data analysis tools. The methodologies found within the book enable the characterization of pathomechanisms of human diseases, support the targeted development of novel drugs and personalized medicine, and also aid in the development of novel chemicals to combat human parasites or to identify undesired effects caused by environmental pollutants. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step and readily reproducible laboratory protocols, and tips for troubleshooting and avoiding known pitfalls. Authoritative and practical, Phenotypic Screening: Methods and Protocols serves as an ideal guide to this growing field that touches areas of basic and translational biomedical research, clinical and pharmaceutical research, biotechnology, toxicology, and bioinformatics. Chapters 2, 3, 4, 5, 6, 7, 8, and 18 are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

Coates presents the face in film as a place where transformations begin, reflecting both the experience of modernity and such influential myths as that of Medusa. This is exemplified by a wide range of European and American films, including Ingmar Bergman's Persona .

This detailed volume explores recent advances in phenotypic screening, such as high-resolution microscopy, high-throughput screening, and artificial intelligence (AI)-based image and data analysis tools. The methodologies found within the book enable the characterization of pathomechanisms of human diseases, support the targeted development of novel drugs and personalized medicine, and also aid in the development of novel chemicals to combat human parasites or to identify undesired effects caused by environmental pollutants. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step and readily reproducible laboratory protocols, and tips for troubleshooting and avoiding known pitfalls. Authoritative and practical, Phenotypic Screening: Methods and Protocols serves as an ideal guide to this growing field that touches areas of basic and translational biomedical research, clinical and pharmaceutical research, biotechnology, toxicology, and bioinformatics. Chapters 2, 3, 4, 5, 6, 7, 8, and 18 are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

Coates presents the face in film as a place where transformations begin, reflecting both the experience of modernity and such influential myths as that of Medusa. This is exemplified by a wide range of European and American films, including Ingmar Bergman's Persona .

Coates presents the face in film as a place where transformations begin, reflecting both the experience of modernity and such influential myths as that of Medusa. This is exemplified by a wide range of European and American films, including Ingmar Bergman's Persona .

Screening for cancer is an important focus of cancer control. Yet screening, as it involves administering a test to large segments of the population deemed to be at risk for the disease of interest, is potentially a major consumer of scarce health care resources. In addition, the benefits sought from cancer screening, particularly reduction in mortality from the disease, are not always realized, either for biological or organizational reasons. Thus, the paradigm that `early detection must always be beneficial', taught to health care professionals, and publicized widely through the media to the public, has been challenged in the last two decades for a number of cancer sites. It is the purpose of Advances in Cancer Screening to determine the extent to which the requirements for the introduction of population-based screening programs have been met, as a result of extensive research on screening during the last two decades, with a major concentration on findings from the recent decade.

More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.